Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from MonumenTAL-1.

被引：0

作者：

Minnema, Monique C.

Krishnan, Amrita Y.

Berdeja, Jesus G.

Rocafiguera, Albert Oriol

van de Donk, Niels W. C. J.

Rodriguez-Otero, Paula

Morillo, Daniel

Mateos, Maria-Victoria

Costa, Luciano J.

Caers, Jo

Vishwamitra, Deeksha

Ma, Joanne

Yang, Shiyi

Hilder, Brandi

Tolbert, Jaszianne A.

Goldberg, Jenna D.

Chari, Ajai

机构：

[1] Univ Med Ctr Utrecht, Utrecht, Netherlands

[2] City Hope Comprehens Canc Ctr, Duarte, CA USA

[3] Sarah Cannon Res Inst, Nashville, TN USA

[4] Hosp Badalona Germans Trias & Pujol, Inst Catal Oncol & Inst Josep Carreras, Badalona, Spain

[5] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands

[6] Clin Univ Navarra, Madrid, Spain

[7] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[8] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[9] Univ Alabama Birmingham, Birmingham, AL USA

[10] Univ Liege, Liege, Belgium

[11] Janssen Res & Dev, Spring House, PA USA

[12] Janssen Res & Dev, Spring House, PA USA

[13] Janssen Res & Dev, Raritan, NJ USA

[14] Mt Sinai Sch Med, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8015

引用

页数：1